LUO Zuqiang, ZHUANG Zhiquan, TU Xiaomeng. Expressions and clinical significances of p57KIP2, cyclin D1 and cyclin E in primary carcinoma of the gallbladder[J]. China Oncology, 2018, (11): 801-806.
LUO Zuqiang, ZHUANG Zhiquan, TU Xiaomeng. Expressions and clinical significances of p57KIP2, cyclin D1 and cyclin E in primary carcinoma of the gallbladder[J]. China Oncology, 2018, (11): 801-806. DOI: 10.19401/j.cnki.1007-3639.2018.11.001.
Expressions and clinical significances of p57KIP2, cyclin D1 and cyclin E in primary carcinoma of the gallbladder
背景与目的:原发性胆囊癌(primary carcinoma of the gallbladder,PCG)是死亡率极高的恶性肿瘤,其恶变的机制目前尚未明确。前期研究发现,p57
KIP2
在人类多种恶性肿瘤中异常表达。本研究拟进一步探讨p57
KIP2
在PCG组织中的表达及临床意义。方法:运用实时荧光定量聚合酶链反应(real-time fluorescence quantitative polymerase chain reaction,RTFQ-PCR)、免疫组织化学EliVision法分别检测60例PCG、20例胆囊腺瘤(adenoma of the gallbladder,AG)和20例慢性胆囊炎(chronic cholecystitis,CC)组织中p57
KIP2
、cyclin D1、cyclin E mRNA表达及蛋白水平。结果:p57
KIP2
mRNA及蛋白在PCG、AG和CC中的表达逐渐升高,两两比较差异有统计学意义(P0.05)。Cyclin D1、cyclin E mRNA及蛋白在PCG、AG和CC中的表达逐渐降低,PCG与AG比较、PCG与CC比较,差异有统计学意义(P0.05)。在PCG组织中,p57
Background and purpose: Primary carcinoma of the gallbladder (PCG) is a malignant tumor with extremely high mortality
and the mechanism of its malignant transformation is not yet clear. Previous studies found abnormal expression of p57
KIP2
in a variety of human malignant
tumors. This study aimed to analyze the expressions of p57
KIP2
cyclin D1 and cyclin E in PCG and their clinical significances. Methods: The mRNA expression and protein levels of p57
KIP2
cyclin D1 and cyclin E in 60 cases of PCG
20 cases of adenoma of the gallbladder (AG) and 20 cases of chronic cholecystitis (CC) were detected by real-time fluorescence quantitative polymerase chain reaction (RTFQ-PCR) and immunohistochemistry
respectively. Results: The mRNA expression and protein levels of p57
KIP2
in PCG
AG and CC increased gradually
and there were significant differences among the three groups (P0.05). The mRNA expression and protein levels of cyclin D1 and cyclin E in PCG
AG and CC decreased gradually. The difference between PCG and AG
or between PCG and CC was statistically significant. In PCG tissues
the protein expression of p57
KIP2
was associated with clinical stage
histological grade and node metastasis (P0.05). The protein level of cyclin D1 was associated with clinical stage (P0.05). There was a negative correlation between the expressions of p57
KIP2
and cyclin D1
or p57
KIP2
and cyclin E. However
the correlation between cyclin D1 and cyclin E expressions was positive (P0.05). Conclusion: Reduced level of p57
KIP2
and overexpression of cyclin E may be one of the mechanisms underlying carcinogenesis of PCG. p57
KIP2
cyclin D1 and cyclin E were independent prognostic factors for PCG.